Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-26 @ 3:25 PM
Study NCT ID:
NCT05728268
Status:
UNKNOWN
Last Update Posted:
2023-02-15
First Post:
2023-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Sponsor:
Shantou Central Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-04
First Submit QC Date:
None
Study First Post Date:
2023-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-04
Last Update Post Date:
2023-02-15
Last Update Post Date Type:
ACTUAL